Characterising and treating osteogenesis imperfecta
1Department of Human Metabolism, University of Sheffield, Sheffield Children's Hospital, Western Bank, UK. n.j.bishop@shef.ac.uk
Insights
Osteogenesis imperfecta, a bone fragility disorder, can be managed with bisphosphonates and supportive therapies, significantly reducing fracture frequency. Early intervention shows promise, but long-term effects on structural outcomes require further investigation.
Area of Science:
- Pediatrics
- Genetics
- Orthopedics
Background:
- Osteogenesis imperfecta (OI) is a genetic disorder characterized by bone fragility, leading to fractures, deformity, pain, and mobility issues.
- Neonatal presentation with fractures can mimic other conditions, necessitating careful clinical differentiation.
- Multidisciplinary management is crucial for addressing the complex needs of individuals with OI.
Purpose of the Study:
- To review the current understanding of osteogenesis imperfecta.
- To evaluate the efficacy of bisphosphonate therapy in managing OI.
- To assess the impact of early intervention on fracture frequency and long-term outcomes.
Main Methods:
- Review of published literature on osteogenesis imperfecta management.
- Analysis of outcomes associated with bisphosphonate therapy.
- Evaluation of multidisciplinary care approaches including physiotherapy and occupational therapy.
Main Results:
- Bisphosphonate therapy, combined with specialized care, can reduce fracture frequency by up to 50%.
- Early initiation of bisphosphonates (around 6 weeks of age) shows significant positive effects on vertebral morphometry.
- Outcomes in older children are encouraging, with similar reductions in fracture frequency.
Conclusions:
- Bisphosphonates are a cornerstone in managing osteogenesis imperfecta, effectively reducing fracture rates.
- While early intervention demonstrates benefits, its long-term impact on severe structural complications like scoliosis and basilar invagination remains uncertain.
- Further research is needed to determine the full long-term effects of early therapeutic interventions in OI.
Abstract:
Osteogenesis imperfecta is characterised by bone fragility leading to fracture and bone deformity, chronic bone pain and reduced mobility. Presentation in infancy may be anticipated through shortened or bowed femurs on antenatal ultrasound scanning, or because of family history. Other conditions can present in the neonatal period with osteoporosis and fractures, but clinical features should allow differentiation. Management is multidisciplinary, with the mainstay of medical intervention being the use of bisphosphonates. Intervention with these medications, in association with specialised nursing, physio- and occupational therapy input, has reduced fracture frequency by up to 50% in published series, and has shown significant effects on vertebral morphometry when started early (around 6 weeks age). Outcomes in older children are encouraging with a reduction in fracture frequency of up to 50%; however, the longer term effects of early intervention remain to be determined. In particular the effects on life-limiting structural outcomes such as scoliosis and basilar invagination remain unclear.
More Related Videos
14:55Analysis of Minerals Produced by hFOB 1.19 and Saos-2 Cells Using Transmission Electron Microscopy with Energy Dispersive X-ray Microanalysis
Published on: June 24, 2018
09:20Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
Published on: December 18, 2019
Related Concept Videos
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling and Repair
Osteoclasts in Bone Remodeling
Bone Formation by Endochondral Ossification
Bone Remodeling
